Romanian Society of Cardiology

DRAGOS VINEREANU

Bucharest, Romania.

PERSONAL DATA:

Date and place of birth:                                                  14th July 1966, Pitesti, Romania

Citizenship:                                                                                        Romanian

EDUCATION:

1984:     High School Diploma, Lyceum “Vlaicu Voda”, Curtea de Arges, Romania.

1990:         MD Diploma, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania. Graduating thesis: “Role of Echocardiography in Cor Pulmonale”.

1994:     Specialist Certificate of Completion of Training in Internal Medicine.

1998:     Specialist Certificate of Completion of Training in Cardiology.

1999:     Consultant in Internal Medicine.

2000:         PhD degree in Internal Medicine at the University of Medicine and Pharmacy Carol Davila, Bucharest, Romania. Title of the thesis: “Follow-up of Patients with Mitral Valve Disease by Transthoracic and Transoesophageal Echocardiography”.

2004:     Consultant in Cardiology.

2005:     MD degree in the Management of Health Systems, University of Bucharest, Romania.

PROFESSIONAL POSTS HELD:

From To Post Speciality Hospital
01/04/2012 Date Vice-rector, Head of the Cardiology Department Cardiology University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
15/12/2009 01/06/2014 Medical Director Cardiology University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
27/02/2006 15/12/2009 Head of the 2nd Department of Cardiology,Professor,

Consultant

 Cardiology University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
1/10/2004 27/02/2006 Head of the 2nd  Department of Cardiology,Associate Professor,

Consultant

 Cardiology University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
1/10/2003 1/10/2004 Associate Professor, Consultant Cardiology and Internal Medicine University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
1/10/2002 1/10/2003 Senior Lecturer,Consultant Cardiology and Internal Medicine University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
1/11/1999 1/10/2002 Lecturer,Consultant Cardiology and Internal Medicine University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
22/10/1998 31/10/1999 Lecturer,Specialist Cardiology and Internal Medicine University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
13/09/1998 21/10/1998 Lecturer,Specialist in Internal Medicine,

SpR in Cardiology

 Cardiology and Internal Medicine University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
23/03/1998 12/09/1998 Research Fellow Cardiology University Hospital of Wales, Cardiff, UK
19/09/1996 22/03/1998 Lecturer,Specialist in Internal Medicine,

SpR in Cardiology

 Cardiology and Internal Medicine University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
10/05/1995 18/09/1996 Visiting Registrar Cardiology University Hospital of Wales, Cardiff, UK
 1/03/1995  9/05/1995 Lecturer,Specialist in Internal Medicine,

SpR in Cardiology

 Internal Medicine and Cardiology University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
1/03/1992  28/02/1995 Junior Lecturer,Registrar Internal Medicine and Cardiology University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania
20/11/1990  28/02/1992 Intern General Medicine University and Emergency Hospital of Bucharest, Romania

 

TEACHING RESPONSIBILITIES:

  • Coordinator of undergraduate training of 4th and 6th year students at the University of Medicine and Pharmacy Carol Davila, Bucharest, Romania;
  • Coordinator of postgraduate training of more than 35 registrars/year, at the University of Medicine and Pharmacy Carol Davila, Bucharest, Romania;
  • National supervisor of the training in “Special Echocardiography” (Complementary Studies);
  • Regional supervisor of the training in “Interventional Cardiology” (Complementary Studies);
  • Involved in more than 1,200 national Continuous Medical Education activities (lecturer and/or national coordinator);
  • Multiple national and international courses, organized by the professional societies (Romanian Society of Cardiology, European Society of Cardiology, etc.).

 

RESEARCH ACTIVITY:

Research activity: 100 grants and multicentric international studies:

  1. a) International grants: 17 (Project Coordinator in 16).
  2. b) National grants: 21 (Project Coordinator in 13).
  3. c) Phase II/III international multicentric studies and international registries: 62

– Principal investigator: 39 (member of the international “Steering Committee”/National Coordinator in 26)

– Investigator: 22

– Member of the Clinical Events Committee: 1

 

SCIENTIFIC ACTIVITY:

  • 138 full-papers published in journals with Impact Factor First, including New England Journal of Medicine, Lancet, Circulation, Journal of the American College of Cardiology, European Heart Journal.
  • 51 full-papers published in national or international journals (indexed in International Databases), and of more than 500 abstracts.
  • Hirsch index: 41 (Google Scholar), with more than 8,000 citations; 34 (WOS) with more than 6,000 citations.
  • Contributed chapters to 54 medical books, published in Romania (45) or abroad (9).

 

EDITORIAL RESPONSIBILITIES:

  • Deputy Editor of “Maedica – a Journal of Clinical Medicine” journal (indexed on PUBMED), Bucharest, Romania.
  • Member of the Editorial Board of “Scientific Reports – Nature Group”; “Echo Research and Practice”, official journal of the British Society of Echocardiography, UK; “American Journal of Therapeutics”; “Romanian Heart Journal”; and „Journal of Translational Medicine and Research”, official journal of the Romanian Academy of Medical Sciences.
  • Member of the peer-review board of many journals, such as Journal of Molecular and Cell Biology, Heart, American Journal of Cardiology, European Journal of Cardiovascular Prevention, Clinical Science, European Journal of Heart Failure, European Heart Journal, JASE, BMJ, etc.

 

Qualifications, Honors:

2000:     European Cardiologist Diploma.

2001:     Fellow of the European Society of Cardiology (FESC).

2008:     Member of the Romanian Academy of Medical Sciences.

2016:     Fellow of the Royal College of Physicians (UK).

2016:     Fulbright Award at Duke University (Visiting Professor).

2017:     Corresponding Member of the Romanian Academy.

 

PAST/PRESENT OFFICE IN A NATIONAL SPECIALITY SOCIETY:

1998-2002:          Secretary of the Working Group “Ischemic Cardiac Disease” of the Romanian Society of Cardiology;

2002-2005:          Secretary of the Working Group “Atherosclerosis” of the Romanian Society of Cardiology;

2005-2008:          Chairman of the Working Group “Atherosclerosis” of the Romanian Society of Cardiology;

2008-2011:          Treasurer of the Romanian Society of Cardiology;

2011-2014:          Vice-president of the Romanian Society of Cardiology;

2014-2017:          President Elect of the Romanian Society of Cardiology;

2017-2020:          President of the Romanian Society of Cardiology.

 

SPECIAL NATIONAL RESPONSIBILITIES:

1996-2003:          Chairman of the Professional and Scientific Department, Romanian College of Physicians;

2002-2006:          Vice-president of the Cardiology Committee of the Romanian College of Physicians;

2005-2006:          Vice-president of the Cardiology Committee of the Ministry of Health, Romania;

2006-2012:          President of the Cardiology Committee of the Romanian College of Physicians;

2005-2016:          Member of the Scientific Council of the National Drug Agency;

2009-date:           President of the Cardiology Committee of the Ministry of Health;

2009-date:           Chairman of the Cardiology Programs Committee of the Ministry of Health.

 

MEMBERSHIPS:

  • Member of the Romanian Society of Cardiology.
  • Member of the Working Group in Heart Failure of the Romanian Society of Cardiology.
  • Member of the Working Group of Atherosclerosis of the Romanian Society of Cardiology.
  • Member of the European Society of Cardiology.
  • Member of the “European Association of Cardiovascular Imaging”.
  • Member of the “European Association of Preventive Cardiology and Rehabilitation of the European Society of Cardiology”.
  • Member of the “Heart Failure Association” of the European Society of Cardiology.
  • Premium Professional Member of the American Heart Association (Member of the Council of Clinical Cardiology and Stroke Council).

ACADEMIC SERVICE:

  • Member of the Contest Board for Lecturer in Internal Medicine at the University of Medicine and Pharmacy “Carol Davila” Bucharest in 1994, 2004, 2005, 2006, 2012-2018.
  • Member of the Contest Board for Senior Lecturer in Internal Medicine at the University of Medicine and Pharmacy “Carol Davila” Bucharest in 2005, 2006, 2009, 2012-2018.
  • Member in the University Admission Contest Committee, University of Medicine and Pharmacy “Carol Davila” Bucharest in 1992, 1993, 1994, 1997.
  • Member of the National Committee for the organization of the contest for medical specialization in 1999, 2000.
  • Member of the Examination Board in Emergency Medicine 2000, 2001.
  • Member of the Examination Board in Cardiology 2005, 2006; Chairman of the Board in 2008, 2012-2018.
  • President of the Examination Board for the competency in Special Echocardiography 2005-2018.
  • President of the Examination Board for the competency in Interventional Cardiology 2018.

AWARDS:

  • Distinguished Faculty Award of the University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
  • Award for Excellence in Cardiology of the Medic.ro Publishing House, Ministry of Health, and the Romanian College of Physicians.
  • The Medical Award of the Romanian Foundation for Art and Sciences of the Romanian Academy.
  • The “Iuliu Hatieganu” Award for “Excellence in medical research” of the Romanian Academy.

 

FELLOWSHIPS:

  • “TEMPUS Fellowship” – 1 month (May, 1993) in the Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
  • “ESC Training Fellowship” – one year (10/05/1995-10/05/1996) in the Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom.
  • “University of Wales College of Medicine Research Fellowship” – 4 months (10/05/1996-18/09/1996) as a Research Fellow in the Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom.
  • “Fellowship of the Ministry of Education, Romania” – 6 months (23/03/1998-12/09/1998) as a Research Fellow in the Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom.
  • “Fellowship of the Heart Research Fund for Wales” – 3 weeks (5/02/1999-27/02/1999) as a Research Fellow in the Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom.
  • “Fellowship of the Heart Research Fund for Wales” – 6 weeks (7/02/2000-17/03/2000) as a Research Fellow in the Wales Heart Research Institute, Cardiff, United Kingdom.
  • Research Fellow Wales Heart Research Institute – 3 months (8/01/2002-14/04/2002), Cardiff, United Kingdom.

FOREIGN LANGUAGES:

English (speaking and writing).

French (speaking and writing).

 

BIBLIOGRAPHY:

Full-papers published in peer-reviewed (impact-factor) journals:

  1. Manganaro R, Marchetta S, Dulgheru R, Ilardi F, Sugimoto T, Robinet S, Cimino S, Go YY, Bernard A, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, López-Fernández T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, van de Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Rosca M, Calin A, Moonen M, Magne J, Cosyns B, Galli E, Donal E, Carerj S, Zito C, Santoro C, Galderisi M, Badano LP, Lang RM, Oury C, Lancellotti P. Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging. 2018. doi: 10.1093/ehjci/jey188.
  2. Alexander KP, Brouwer MA, Mulder H, Vinereanu D, Lopes RD, Proietti M, Al-Khatib SM, Hijazi Z, Halvorsen S, Hylek EM, Verheugt FWA, Alexander JH, Wallentin L, Granger CB; ARISTOTLE Investigators. Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial. Am Heart J. 2018. doi: 10.1016/j.ahj.2018.09.017.
  3. Mărgulescu AD, Şuran MC, Vinereanu D. Do 2-Dimensional Speckle Tracking Indexes Have Sufficient Reproducibility to Be Used in Clinical Practice When Image Acquisition and Severity of LV Dysfunction Are Taken Into Account? JACC Cardiovasc Imaging 2018. doi: 10.1016/j.jcmg.2018.09.011.
  4. Dumitrescu A, Mosteoru S, Vinereanu D, Dan GA, Gaita L, Gaita D. Preliminary data of familial hypercholesterolemia (FH) patients in Romania. Atherosclerosis; 277: 304-307.
  5. Sharma M, Hart RG, Smith EE, Bosch J, Yuan F, Casanova A, Eikelboom JW, Connolly SJ, Wong G, Diaz R, Lopez-Jaramillo P, Ertl G, Störk S, Dagenais GR, Lonn EM, Ryden L, Tonkin AM, Varigos JD, Bhatt DL, Branch KR, Probstfield JL, Kim JH, Ha JW, O’Donnell M, Vinereanu D, Fox KA, Liang Y, Liu L, Zhu J, Pogosova N, Maggioni AP, Avezum A, Piegas LS, Keltai K, Keltai M, Cook Bruns N, Berkowitz S, Yusuf S. Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial. Int J Stroke 2018. doi: 10.1177/1747493018784478.
  6. Macarie RD, Vadana M, Ciortan L, Tucureanu MM, Ciobanu A, Vinereanu D, Manduteanu I, Simionescu M, Butoi E. The expression of MMP-1 and MMP-9 is up-regulated by smooth muscle cells after their cross-talk with macrophages in high glucose conditions. J Cell Mol Med. 2018; 22: 4366-4376.
  7. Solomon SD, Rizkala AR, Lefkowitz MP, Shi VC, Gong J, Anavekar N, Anker SD, Arango JL, Arenas JL, Atar D, Ben-Gal T, Boytsov SA, Chen CH, Chopra VK, Cleland J, Comin-Colet J, Duengen HD, Echeverría Correa LE, Filippatos G, Flammer AJ, Galinier M, Godoy A, Goncalvesova E, Janssens S, Katova T, Køber L, Lelonek M, Linssen G, Lund LH, O’Meara E, Merkely B, Milicic D, Oh BH, Perrone SV, Ranjith N, Saito Y, Saraiva JF, Shah S, Seferovic PM, Senni M, Sibulo AS Jr, Sim D, Sweitzer NK, Taurio J, Vinereanu D, Vrtovec B, Widimský J Jr, Yilmaz MB, Zhou J, Zweiker R, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial. Circ Heart Fail. 2018; 11: e004962.
  8. Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G, Bruckert E, Descamps O, Djuric DM, Ezhov M, Fras Z, von Haehling S, Katsiki N, Langlois M, Latkovskis G, Mancini GBJ, Mikhailidis DP, Mitchenko O, Moriarty PM, Muntner P, Nikolic D, Panagiotakos DB, Paragh G, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Rosano GMC, Rosenson RS, Rysz J, Sahebkar A, Serban MC, Vinereanu D, Vrablík M, Watts GF, Wong ND, Rizzo M; International Lipid Expert Panel (ILEP). The Role of Nutraceuticals in Statin Intolerant Patients. J Am Coll Cardiol. 2018; 72: 96-118.
  9. Thavendiranathan P, Negishi T, Coté MA, Penicka M, Massey R, Cho GY, Hristova K, Vinereanu D, Popescu BA, Izumo M, Negishi K, Marwick TH; SUCCOUR Investigators. Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy. JACC Cardiovasc Imaging 2018; 11: 1109-1118.
  10. Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E. Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study. Adv Ther. 2018; 35: 604-618.
  11. Sugimoto T, Robinet S, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, Caballero L, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, van de Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Go YY, Marchetta S, Nchimi A, Rosca M, Calin A, Moonen M, Cimino S, Magne J, Cosyns B, Galli E, Donal E, Habib G, Esposito R, Galderisi M, Badano LP, Lang RM, Lancellotti P; NORRE Study. Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 2018; 19: 630-638.
  12. Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L; ARISTOTLE Committees and Investigators. Digoxin and Mortality in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2018; 71: 1063-1074.
  13. Mincu RI, Magda SL, Mihaila S, Florescu M, Mihalcea DJ, Velcea A, Chiru A, Tiu C, Popescu BO, Cinteza M, Vinereanu D. Impaired Cardiac Function in Patients with Multiple Sclerosis by Comparison with Normal Subjects. Sci Rep. 2018; 8: 3300.
  14. Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. Am Heart J. 2018; 197: 133-141.
  15. Vinereanu D, Wang A, Mulder H, Lopes RD, Jansky P, Lewis BS, Gersh BJ, Avezum A, Hanna M, Held C, Wallentin L, Granger CB, Alexander JH. Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease. Heart 2018; 104: 1292-1299.
  16. Rimbaş RC, Baldea SM, Guerra RDGA, Visoiu SI, Rimbaş M, Pop CS, Vinereanu D. New Definition Criteria of Myocardial Dysfunction in Patients with Liver Cirrhosis: A Speckle Tracking and Tissue Doppler Imaging Study. Ultrasound Med Biol. 2018; 44: 562-574.
  17. Vinereanu D, Mǎrgulescu AD. The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction: reply. Eur J Heart Fail. 2018; 20: 619-620.
  18. Vinereanu D, Lopes RD, Bahit MC, Xavier D, Jiang J, Al-Khalidi HR, He W, Xian Y, Ciobanu AO, Kamath DY, Fox KA, Rao MP, Pokorney SD, Berwanger O, Tajer C, de Barros E Silva PGM, Roettig ML, Huo Y, Granger CB. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet 2017; 390: 1737-46.
  19. Vinereanu D, Al-Khalidi HR, Rao MP, He W, Lopes RD, Bahit CM, Ciobanu AO, Fox KA, Pokorney SD, Xian Y, Jiang J, Kamath DY, Berwanger O, Tajer C, Huo Y, Xavier D, Granger CB. Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF). Am Heart J. 2017; 192: 38-47.
  20. Vinereanu D, Lopes RD, Mulder H, Gersh BJ, Hanna M, de Barros E Silva PGM, Atar D, Wallentin L, Granger CB, Alexander JH. Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin. Stroke 2017; 48: 3266-73.
  21. Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O’Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017; 377: 1319-30.
  22. Rao MP, Vinereanu D, Wojdyla DM, Alexander JH, Atar D, Hylek EM, Hanna M, Wallentin L, Lopes RD, Gersh BJ, Granger CB. Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial. Am J Med. 2018; 131: 269-75.
  23. Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O’Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 2018; 391: 219-29.
  24. Vinereanu D, Mǎrgulescu AD. The fallacy of resting echocardiographic parameters of cardiac function in heart failure with preserved ejection fraction: add global longitudinal strain to the list. Eur J Heart Fail. 2017; 19: 901-3.
  25. Stoicescu C, Vinereanu D, Kilic ID, Nasifov M, Goktekin O, Sawaya F, Millan-Iturbe O, Søndergaard L. How should I treat an iatrogenic type IIA DeBakey-Stanford aortic dissection during a percutaneous right coronary artery intervention? EuroIntervention 2017; 13: e1124-8.
  26. Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev. 2017; 75: 731-67.
  27. Guimarães PO, Granger CB, Stebbins A, Chiswell K, Held C, Hochman JS, Krug-Gourley S, Lonn E, Lopes RD, Stewart RAH, Vinereanu D, Wallentin L, White HD, Hagström E, Danchin N. Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J Am Heart Assoc. 2017; 6: pii: e006695.
  28. Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci. 2017; 13: 965-1005.
  29. Bosch J, Eikelboom JW, Connolly SJ, Bruns NC, Lanius V, Yuan F, Misselwitz F, Chen E, Diaz R, Alings M, Lonn EM, Widimsky P, Hori M, Avezum A, Piegas LS, Bhatt DL, Branch KRH, Probstfield JL, Liang Y, Liu L, Zhu J, Maggioni AP, Lopez-Jaramillo P, O’Donnell M, Fox KAA, Kakkar A, Parkhomenko AN, Ertl G, Störk S, Keltai K, Keltai M, Ryden L, Dagenais GR, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Ha JW, Tonkin AM, Varigos JD, Lewis BS, Felix C, Yusoff K, Steg PG, Aboyans V, Metsarinne KP, Anand SS, Hart RG, Lamy A, Moayyedi P, Leong DP, Sharma M, Yusuf S. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. Can J Cardiol. 2017; 33: 1027-35. doi: 10.1016/j.cjca.2017.06.001.
  30. Sugimoto T, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, Caballero L,vAkhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A,vHristova K, Lopez T, de la Morena G, Popescu BA, Moonen M, Penicka M, Ozyigit T, Rodrigo Carbonero JD, van de Veire N, von Bardeleben RS, Vinereanu D, Zamorano JL, Go YY, Rosca M, Calin A, Magne J, Cosyns B, Marchetta S, Donal E, Habib G, Galderisi M, Badano LP, Lang RM, Lancellotti P. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging. 2017; 18: 833-40.
  31. Bernard A, Addetia K, Dulgheru R, Caballero L, Sugimoto T, Akhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Ilardi F, Lopez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, David Rodrigo Carbonero J, van de Veire N, Stephan Von Bardeleben R, Vinereanu D, Luis Zamorano J, Martinez C, Magne J, Cosyns B, Donal E, Habib G, Badano LP, Lang RM, Lancellotti P. 3D echocardiographic reference ranges for normal left ventricular volumes and strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging. 2017; 18: 475-83.
  32. Vinereanu D. Sacubitril-Valsartan for Heart Failure: From Devil’s Advocate to Evidence-Based Medicine. Am J Ther 2017; 24: e109-e110.
  33. Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E. Early Treatment With Zofenopril And Ramipril In Combination With Acetyl Salicylic Acid In Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results Of A 5-Year Follow-Up Of Patients Of The Smile-4 Study. J Cardiovasc Pharmacol 2017; 69: 298-304.
  34. Mincu RI, Jánosi RA, Vinereanu D, Rassaf T, Totzeck M. Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis. Sci Rep 2017; 7: 41530.
  35. Rimbas RC, Călin SI, Ionescu H, Dorobat B, Vinereanu D, Cinteza M. An extensive suprarenal inferior vena cava thrombosis successfully treated with catheter-directed thrombolysis in a postpartum 14-year-old girl. Vasa 2017; 46: 227-30.
  36. Bahit MC, Lopes RD, Wojdyla DM, Held C, Hanna M, Vinereanu D, Hylek EM, Verheugt F, Goto S, Alexander JH, Wallentin L, Granger CB. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation. Heart 2017; 103: 623-8.
  37. Negishi T, Negishi K, Thavendiranathan P, Cho GY, Popescu BA, Vinereanu D, Kurosawa K, Penicka M, Marwick TH; SUCCOUR Investigators.. Effect of Experience and Training on the Concordance and Precision of Strain Measurements. JACC Cardiovasc Imaging 2017; 10: 518-22.
  38. Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E; SMILE-4 Working Party. Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study. J Renin Angiotensin Aldosterone Syst. 2016; 17(4). pii: 1470320316656480.
  39. Jaroch J, Łoboz-Grudzień K, Magda S, Florescu M, Bociąga Z, Ciobanu AO, Kruszyńska E, Dudek K, Vinereanu D. The Relationship of Carotid Arterial Stiffness and Left Ventricular Concentric Hypertrophy in Hypertension. Adv Clin Exp Med. 2016; 25: 263-72.
  40. Rimbaş RC, Mihăilă S, Enescu OA, Vinereanu D. A new comprehensive 12-segment approach to right ventricular systolic and diastolic functions by 2D speckle tracking echocardiography in healthy individuals. Echocardiography 2016; 33: 1866-73.
  41. Suran MC, Margulescu AD, Siliste C, Vinereanu D. Inappropriate implantable cardioverter-defibrillator shock in unusual circumstances. Acta Cardiol 2016; 71: 369-70.
  42. Kristensen SL, Martinez F, Jhund PS, Arango JL, Bĕlohlávek J, Boytsov S, Cabrera W, Gomez E, Hagège AA, Huang J, Kiatchoosakun S, Kim KS, Mendoza I, Senni M, Squire IB, Vinereanu D, Wong RC, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJ. Geographic variations in the PARADIGM-HF heart failure trial. Eur Heart J 2016; 37: 3167-74.
  43. Rao MP, Ciobanu AO, Lopes RD, Fox KA, Xian Y, Pokorney SD, Al-Khalidi HR, Jiang J, Kamath DY, Berwanger O, Xavier D, Bahit CM, Tajer C, Vinereanu D, Huo Y, Granger CB. A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale. Am Heart J 2016; 176: 107-13.
  44. Mihalcea DJ, Florescu M, Vinereanu D. Mechanisms and Genetic Susceptibility of Chemotherapy-Induced Cardiotoxicity in Patients With Breast Cancer. Am J Ther 2016; 24: e3-e11.
  45. Saura D, Dulgheru R, Caballero L, Bernard A, Kou S, Gonjilashvili N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, Van De Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Gori AS, Cosyns B, Donal E, Habib G, Addetia K, Lang RM, Badano LP, Lancellotti P. Two-dimensional transthoracic echocardiographic normal reference ranges for proximal aorta dimensions: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging. 2017; 18: 167-79.
  46. Borghi C, Omboni S, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E. Zofenopril and ramipril in combination with acetyl salicylic acid in post-myocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis of the SMILE-4 randomized, double-blind study in diabetic patients. Cardiovasc Ther. 2016;34(2):76-84.
  47. Rimbaş RC, Dulgheru RE, Vinereanu D. Methodological Gaps in Left Atrial Function Assessment by 2D Speckle Tracking Echocardiography. Arq Bras Cardiol. 2015; 105(6): 625-36.
  48. Mihaila S, Muraru D, Miglioranza MH, Piasentini E, Aruta P, Cucchini U, Iliceto S, Vinereanu D, Badano LP. Relationship between mitral annulus function and mitral regurgitation severity and left atrial remodelling in patients with primary mitral regurgitation. Eur Heart J Cardiovasc Imaging. 2016 Jan 12. [Epub ahead of print]
  49. Margulescu AD, Enescu OA, Vinereanu D. A regularly irregular rhythm-what is the diagnosis? Neth Heart J. 2016; 24(2): 156-8.
  50. Vedin O, Hagström E, Budaj A, Denchev S, Harrington RA, Koenig W, Soffer J, Sritara P, Stebbins A, Stewart RH, Swart HP, Viigimaa M, Vinereanu D, Wallentin L, White HD, Held C; STABILITY Investigators. Tooth loss is independently associated with poor outcomes in stable coronary heart disease. Eur J Prev Cardiol. 2016; 23(8): 839-46.
  51. Lopatin YM, Rosano GM, Fragasso G, Lopaschuk GD, Seferovic PM, Gowdak LH, Vinereanu D, Hamid MA, Jourdain P, Ponikowski P. Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure. Int J Cardiol. 2016; 203: 909-15.
  52. Störk S, Kavoliuniene A, Vinereanu D, Ludwig R, Seferovic P, Dickstein K, Anker SD, Filippatos G, Ponikowski P, Lainscak M. What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative. Eur J Heart Fail. 2016; 18(1): 66-70.
  53. Vinereanu D, Stevens SR, Alexander JH, Al-Khatib SM, Avezum A, Bahit MC, Granger CB, Lopes RD, Halvorsen S, Hanna M, Husted S, Hylek EM, Mărgulescu AD, Wallentin L, Atar D. Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. Eur Heart J. 2015; 36(46): 3268-75.
  54. Filimon AM, Negreanu L, Doca M, Ciobanu A, Preda CM, Vinereanu D. Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons. World J Gastroenterol. 2015; 21(33): 9688-92.
  55. Mărgulescu AD, Şuran MC, Vinereanu D. Letter to the Editor-Left atrial function may not be an independent predictor for CRT response: Implications of ventricular-atrial linking. Heart Rhythm. 2015; 12(12): e141.
  56. Ciobanu AO, Bennett S, Lopes RD, Vinereanu D. Isolated Double Orifice Mitral Valve – a Rare Finding in an Elderly Man. Arq Bras Cardiol. 2015; 104(5): e53-4.
  57. Mihaila S, Mincu RI, Rimbas RC, Dulgheru RE, Dobrescu R, Magda SL, Badiu C, Vinereanu D. Growth hormone deficiency in adults impacts left ventricular mechanics: a two-dimensional speckle-tracking study. Can J Cardiol. 2015; 31(6): 752-9.
  58. Caballero L, Kou S, Dulgheru R, Gonjilashvili N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez de Diego JJ, Oliva MJ, Hagendorff A, Hristova K, Lopez T, Magne J, Martinez C, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, Salustri A, Van De Veire N, Von Bardeleben RS, Vinereanu D, Voigt JU, Zamorano JL, Bernard A, Donal E, Lang RM, Badano LP, Lancellotti P. Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study. Eur Heart J Cardiovasc Imaging. 2015; 16(9): 1031-41.
  59. Cornel JH, Lopes RD, James S, Stevens SR, Neely ML, Liaw D, Miller J, Mohan P, Amerena J, Raev D, Huo Y, Urina-Triana M, Gallegos Cazorla A, Vinereanu D, Fridrich V, Harrington RA, Wallentin L, Alexander JH; APPRAISE-2 Study Group. Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial. Am Heart J 2015; 169(4): 531-8.
  60. Margulescu AD, Rees E, Coulson RM, Rees AD, Vinereanu D, Fraser AG. Do left atrial strain and strain rate reflect intrinsic atrial function or are they determined by left ventricular function? Kardiol Pol. 2015; 73(7): 539-48.
  61. Mihalcea DJ, Florescu M, Suran BM, Enescu OA, Mincu RI, Magda S, Patrascu N, Vinereanu D. Comparison of pulse wave velocity assessed by three different techniques: Arteriograph, Complior, and Echo-tracking. Heart Vessels 2015 [Epub ahead of print].
  62. McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, Rizkala A, Shi V, Rouleau J, Solomon S, Swedberg K, Zile MR, Andersen K, Arango JL, Arnold M, Bĕlohlávek J, Böhm M, Boytsov S, Burgess L, Cabrera W, Chen CH, Erglis A, Fu M, Gomez E, Gonzalez A, Hagege AA, Katova T, Kiatchoosakun S, Kim KS, Bayram E, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires F, Refsgaard J, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire I, Starling RC, Vinereanu D, Teerlink JR, Wong R; PARADIGM-HF Committees and Investigators. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J 2015; 36(7): 434-9.
  63. Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation. 2015; 131(1): 54-61.
  64. Rimbaş RC, Mihăilă S, Vinereanu D. Sources of variation in assessing left atrial functions by 2D speckle-tracking echocardiography. Heart Vessels 2014 [Epub ahead of print].
  65. Garcia D, Alexander JH, Wallentin L, Wojdyla DM, Thomas L, Hanna M, Al-Khatib SM, Dorian P, Ansell J, Commerford P, Flaker G, Lanas F, Vinereanu D, Xavier D, Hylek EM, Held C, Verheugt FW, Granger CB, Lopes RD. Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. Blood 2014; 124(25): 3692-8.
  66. Mihaila S, Muraru D, Miglioranza MH, Piasentini E, Peluso D, Cucchini U, Iliceto S, Vinereanu D, Badano LP. Normal mitral annulus dynamics and its relationships with left ventricular and left atrial function. Int J Cardiovasc Imaging 2015; 31(2): 279-90.
  67. Vinereanu D, Dulgheru R, Magda S, Dragoi Galrinho R, Florescu M, Cinteza M, Granger C, Ciobanu AO. The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: results of a randomized trial. Am Heart J 2014; 168(4): 446-56.
  68. Chioncel O, Ambrosy AP, Bubenek S, Filipescu D, Vinereanu D, Petris A, Christodorescu R, Macarie C, Gheorghiade M, Collins SP; the Romanian Acute Heart Failure Syndromes study investigators. Epidemiology, pathophysiology, and in-hospital management of pulmonary edema: data from the Romanian Acute Heart Failure Syndromes registry. J Cardiovasc Med (Hagerstown). 2016; 17(2): 92-104.
  69. Negishi K, Negishi T, Kurosawa K, Hristova K, Popescu BA, Vinereanu D, Yuda S, Marwick TH. Practical Guidance in Echocardiographic Assessment of Global Longitudinal Strain. JACC Cardiovasc Imaging. 2015; 8(4): 489-92.
  70. Siliste C, Suran MC, Margulescu AD, Vinereanu D. Right Ventricular Electrical and Mechanical Synchronization by Properly Timed Septal Pacing in a Patient with Right Bundle Branch Block and First Degree AV Block – A Case Report. Ann Noninvasive Electrocardiol 2015; 20(2): 193-7.
  71. Kocabay G, Muraru D, Peluso D, Cucchini U, Mihaila S, Padayattil-Jose S, Gentian D, Iliceto S, Vinereanu D, Badano LP. Normal left ventricular mechanics by two-dimensional speckle-tracking echocardiography. Reference values in healthy adults. Rev Esp Cardiol (Engl Ed). 2014; 67(8): 651-8.
  72. Mihăilă S, Muraru D, Piasentini E, Miglioranza MH, Peluso D, Cucchini U, Iliceto S, Vinereanu D, Badano LP. Quantitative analysis of mitral annular geometry and function in healthy volunteers using transthoracic three-dimensional echocardiography. J Am Soc Echocardiogr. 2014; 27(8): 846-57.
  73. Rimbaş RC, Vinereanu D. Left atrial regional phasic strain, strain rate and velocity by speckle-tracking echocardiography: normal values and effects of aging in a large group of normal subjects – our reply. Int J Cardiol 2014; 174(1): 219-22.
  74. Chioncel O, Ambrosy AP, Filipescu D, Bubenek S, Vinereanu D, Petris A, Collins SP, Macarie C, Gheorghiade M; Romanian Acute Heart Failure Syndromes (RO-AHFS) Study Investigators. Patterns of intensive care unit admissions in patients hospitalized for heart failure: insights from the RO-AHFS registry. J Cardiovasc Med (Hagerstown) 2015; 16(5): 331-40.
  75. STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med 2014; 370(18): 1702-11.
  76. Kou S, Caballero L, Dulgheru R, Voilliot D, De Sousa C, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez De Diego JJ, Hagendorff A, Henri C, Hristova K, Lopez T, Magne J, De La Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, Salustri A, Van De Veire N, Von Bardeleben RS, Vinereanu D, Voigt JU, Zamorano JL, Donal E, Lang RM, Badano LP, Lancellotti P. Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study. Eur Heart J Cardiovasc Imaging 2014; 15(6): 680-90.
  77. Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola VP, Held C, Horowitz J, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJ, Oh BH, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB. Response to letter regarding article, „Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation”. Circulation 2014; 129(2): e21-2.
  78. Florescu M, Magda LS, Enescu OA, Jinga D, Vinereanu D. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer. J Am Soc Echocardiogr 2014; 27(1): 83-92.
  79. Ambrosy AP, Gheorghiade M, Bubenek S, Vinereanu D, Vaduganathan M, Macarie C, Chioncel O; Romanian Acute Heart Failure Syndromes (RO-AHFS) study investigators. The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry. Eur Heart J Acute Cardiovasc Care 2013; 2(2): 99-108.
  80. Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B, Zhu J, Mohan P, Garcia D, Bartunek J, Vinereanu D, Husted S, Harjola VP, Rosenqvist M, Alexander JH, Granger CB; ARISTOTLE Committees and Investigators. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation). J Am Coll Cardiol. 2014; 63(11): 1082-7.
  81. Garcia DA, Wallentin L, Lopes RD, Thomas L, Alexander JH, Hylek EM, Ansell J, Hanna M, Lanas F, Flaker G, Commerford P, Xavier D, Vinereanu D, Yang H, Granger CB. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. Am Heart J 2013; 166(3): 549-58.
  82. Ciobanu AO, Griffin SC, Bennett S, Vinereanu D. Catastrophic mitral prosthesis dehiscence diagnosed by three-dimensional transesophageal echocardiography. J Clin Ultrasound 2014; 42(4): 249-51.
  83. Seferovic PM, Stoerk S, Filippatos G, Mareev V, Kavoliuniene A, Ristic AD, Ponikowski P, McMurray J, Maggioni A, Ruschitzka F, van Veldhuisen DJ, Coats A, Piepoli M, McDonagh T, Riley J, Hoes A, Pieske B, Dobric M, Papp Z, Mebazaa A, Parissis J, Ben Gal T, Vinereanu D, Brito D, Altenberger J, Gatzov P, Milinkovic I, Hradec J, Trochu JN, Amir O, Moura B, Lainscak M, Comin J, Wikström G, Anker S; Committee of National Heart Failure Societies or Working Groups of the Heart Failure Association of the European Society of Cardiology. Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups. Eur J Heart Fail 2013; 15(9): 947-59.
  84. Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation. 2013; 128(3): 237-43.
  85. Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola VP, Held C, Horowitz JD, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJ, Oh BH, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation 2013; 127(22): 2166-76.
  86. Huber K, Connolly SJ, Kher A, Christory F, Dan GA, Hatala R, Kiss RG, Meier B, Merkely B, Pieske B, Potpara T, Stępińska J, Klun NV, Vinereanu D, Widimský P. Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation. Int J Clin Pract 2013; 67(6): 516-26.
  87. Borghi C, Ambrosioni E, Omboni S, Cicero AF, Bacchelli S, Esposti DD, Vinereanu D, Ambrosio G, Zava D; SMILE-4 Working Party. Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study. J Hypertens 2013; 31(6): 1256-64.
  88. Dulgheru R, Magne J, Capoulade R, Davin L, Vinereanu D, Pierard LA, Pibarot P, Lancellotti P. Impact of global hemodynamic load on exercise capacity in aortic stenosis. Int J Cardiol. 2013; 168(3): 2272-7.
  89. Hijazi Z, Oldgren J, Wallentin L, Andersson U, Connolly SJ, Yusuf S, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A. Response to letter regarding article, „Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy”. Circulation 2013; 127(2): e278-9.
  90. Lancellotti P, Badano LP, Lang RM, Akhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez de Diego JJ, Derumeaux G, Dulgheru R, Edvardsen T, Galderisi M, Gonçalves A, Habib G, Hagendorff A, Hristova K, Kou S, Lopez T, Magne J, de la Morena G, Popescu BA, Penicka M, Rasit T, Rodrigo Carbonero JD, Salustri A, Van de Veire N, von Bardeleben RS, Vinereanu D, Voigt JU, Voilliot D, Zamorano JL, Donal E, Maurer G. Normal Reference Ranges for Echocardiography: rationale, study design, and methodology (NORRE Study). Eur Heart J Cardiovasc Imaging 2013; 14(4): 303-8.
  91. Lopes RD, Al-Khatib SM, Wallentin L, Yang H, Ansell J, Bahit MC, De Caterina R, Dorian P, Easton JD, Erol C, Ezekowitz JA, Gersh BJ, Granger CB, Hohnloser SH, Horowitz J, Hylek EM, McMurray JJ, Mohan P, Vinereanu D, Alexander JH. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet 2012; 380(9855): 1749-58.
  92. Tatu-Chiţoiu G, Arafat R, Deleanu D, Vinereanu D, Udroiu C, Petris A. Impact of the Romanian national programme for interventional therapy in ST-elevation myocardial infarction. EuroIntervention 2012; 8 Suppl P:P126-32.
  93. Borghi C, Ambrosioni E, Novo S, Vinereanu D, Ambrosio G; SMILE-4 Working Party. Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4). Clin Cardiol 2012; 35(7): 416-23.
  94. Vintila VD, Roberts A, Vinereanu D, Fraser AG. Progression of subclinical myocardial dysfunction in type 2 diabetes after 5 years despite improved glycemic control. Echocardiography 2012; 29(9): 1045-53.
  95. Mǎrgulescu AD, Suran BM, Rimbaş RC, Dulgheru RE, Silişte C, Vinereanu D. Accuracy of fluoroscopic and electrocardiographic criteria for pacemaker lead implantation by comparison with three-dimensional echocardiography. J Am Soc Echocardiogr 2012; 25(7): 796-803.
  96. Mărgulescu AD, Rimbaş RC, Florescu M, Dulgheru RE, Cinteză M, Vinereanu D. Cardiac adaptation in acute hypertensive pulmonary edema. Am J Cardiol 2012; 109(10): 1472-81.
  97. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation 2012; 125(13): 1605-16.
  98. Magda SL, Ciobanu AO, Florescu M, Vinereanu D. Comparative reproducibility of the noninvasive ultrasound methods for the assessment of vascular function. Heart Vessels 2013; 28(2): 143-50.
  99. Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011; 365(24): 2268-76.
  • Florescu M, Benea DC, Rimbas RC, Cerin G, Diena M, Lanzzillo G, Enescu OA, Cinteza M, Vinereanu D. Myocardial systolic velocities and deformation assessed by speckle tracking for early detection of left ventricular dysfunction in asymptomatic patients with severe primary mitral regurgitation. Echocardiography 2012; 29(3): 326-33.
  • Vinereanu D, Mädler CF, Gherghinescu C, Ciobanu AO, Fraser AG. Cumulative impact of cardiovascular risk factors on regional left ventricular function and reserve: progressive long-axis dysfunction with compensatory radial changes. Echocardiography 2011; 28(8): 813-20.
  • Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators. Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 2011; 365(8): 699-708.
  • Chioncel O, Vinereanu D, Datcu M, Ionescu DD, Capalneanu R, Brukner I, Dorobantu M, Ambrosy A, Macarie C, Gheorghiade M. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J 2011; 162(1): 142-53.e1.
  • Sisu RC, Vinereanu D. Different mechanisms for diastolic mitral regurgitation illustrated by three comparative cases. Echocardiography 2011; 28(4): 476-9.
  • Sisu RC, Lanzillo G, Benea DC, Cerin G, Vinereanu D. A rare association between mitral valve fibroelastoma and myxomatous disease with severe mitral regurgitation. J Clin Ultrasound 2011; 39(3): 179-81.
  • Vinereanu D, Gherghinescu C, Ciobanu AO, Magda S, Niculescu N, Dulgheru R, Dragoi R, Lautaru A, Cinteza M, Fraser AG. Reversal of subclinical left ventricular dysfunction by antihypertensive treatment: a prospective trial of nebivolol against metoprolol. J Hypertens 2011; 29(4): 809-17.
  • Margulescu AD, Sisu RC, Dulgheru R, Vinereanu D. Inaccuracy of radiological and ECG criteria for right ventricular outflow tract implantation of pacemaker leads. Europace 2011; 13(3): 440-1.
  • Ciobanu A, Bennett S, Azam M, Clark A, Vinereanu D. Incremental value of three-dimensional transoesophageal echocardiography for guiding double percutaneous MitraClip ® implantation in a ‚no option’ patient. Eur J Echocardiogr 2011; 12(2): E11.
  • Sisu RC, Bicescu G, Vinereanu D. Massive atelectasis with acute respiratory failure in postpartum misdiagnosed as pulmonary embolism. Am J Emerg Med 2010; 28(7): 842.e1-4.
  • Margulescu AD, Siliste C, Cinteza M, Vinereanu D. Difficulty of assessing response to resynchronization therapy by echocardiographic dyssynchrony indices: an everyday case. Echocardiography 2010; 27(7): 888-93.
  • Florescu M, Stoicescu C, Magda S, Petcu I, Radu M, Palombo C, Cinteza M, Lichiardopol R, Vinereanu D. „Supranormal” cardiac function in athletes related to better arterial and endothelial function. Echocardiography 2010; 27(6): 659-67.
  • Margulescu AD, Thomas DE, Ingram TE, Vintila VD, Egan MA, Vinereanu D, Fraser AG. Can isovolumic acceleration be used in clinical practice to estimate ventricular contractile function? Reproducibility and regional variation of a new noninvasive index. J Am Soc Echocardiogr 2010; 23(4): 423-31, 431.e1-6.
  • Siliste C, Margulescu AD, Vinereanu D. Successful slow pathway ablation in a patient with persistent left superior vena cava. Europace 2010; 12(1): 141-2.
  • Florescu M, Benea DC, Cerin G, Lanzillo G, Diena M, Cernigliaro C, Cinteza M, Vinereanu D. Aorto-pulmonary fistula as a late complication of multiple valve replacement after Streptococcus Bovis endocarditis in a patient with occult colon carcinoma. J Clin Ultrasound 2009; 37(6): 369-73.
  • Margulescu AD, Vinereanu D, Cinteza M. Diastolic mitral regurgitation in 2:1 atrioventricular block. Echocardiography 2009; 26(2): 228-9.
  • Vinereanu D. Mitral regurgitation and cardiac resynchronization therapy. Echocardiography 2008; 25(10): 1155-66.
  • Siliste C, Vinereanu D, Margulescu AD, Cinteza M. Right ventricular outflow tract implantation of an active fixation defibrillation lead through a persistent left superior vena cava. Europace 2008; 10(12): 1454-5.
  • Margulescu AD, Sisu RC, Cinteza M, Vinereanu D. Noncardiogenic acute pulmonary edema due to severe hypoglycemia–an old but ignored cause. Am J Emerg Med 2008; 26(7): 839.e3-6.
  • Vinereanu D. Risk factors for atherosclerotic disease: present and future. Herz 2006; 31 Suppl 3: 5-24.
  • Vinereanu D, Turner MS, Bleasdale RA, Mumford CE, Cinteza M, Frenneaux MP, Fraser AG. Mechanisms of reduction of mitral regurgitation by cardiac resynchronization therapy. J Am Soc Echocardiogr 2007; 20(1): 54-62.
  • Owen PJ, Rajiv C, Vinereanu D, Mathew T, Fraser AG, Lazarus JH. Subclinical hypothyroidism, arterial stiffness, and myocardial reserve. J Clin Endocrinol Metab 2006; 91(6): 2126-32.
  • Dorobantu M, Tatu-Chitoiu G, Cinteza M, Vinereanu D, Ginghina C, Vintila M, Nechita A, Sinescu C, Fruntelata A. [Thrombolysis: Bucarest registry]. Arch Mal Coeur Vaiss 2005; 98(11): 1166-70.
  • Vinereanu D, Nicolaides E, Tweddel AC, Fraser AG. „Pure” diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005; 7(5): 820-8.
  • Vinereanu D, Lim PO, Frenneaux MP, Fraser AG. Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure – a comparison with brain natriuretic peptide. Eur J Heart Fail 2005; 7(4): 512-9.
  • Vinereanu D, Bleasdale R, Turner M, Frenneaux MP, Fraser AG. Comparison of left ventricular-biventricular pacing on ventricular synchrony, mitral regurgitation, and global left ventricular function in patients with severe chronic heart failure. Am J Cardiol 2004; 15; 94(4):519-21.
  • Rajiv C, Vinereanu D, Fraser AG. Tissue Doppler imaging for the evaluation of patients with hypertrophic cardiomyopathy. Curr Opin Cardiol 2004; 19(5): 430-6.
  • Turner MS, Bleasdale RA, Vinereanu D, Mumford CE, Paul V, Fraser AG, Frenneaux MP. Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle-branch block: impact of left and biventricular pacing. Circulation 2004; 109(21): 2544-9.
  • Vinereanu D, Bajaj BP, Fenton-May J, Rogers MT, Mädler CF, Fraser AG. Subclinical cardiac involvement in myotonic dystrophy manifesting as decreased myocardial Doppler velocities. Neuromuscul Disord 2004; 14(3): 188-94.
  • Vinereanu D, Nicolaides E, Tweddel AC, Mädler CF, Holst B, Boden LE, Cinteza M, Rees AE, Fraser AG. Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond) 2003; 105(5): 591-9.
  • Vinereanu D, Nicolaides E, Boden L, Payne N, Jones CJ, Fraser AG. Conduit arterial stiffness is associated with impaired left ventricular subendocardial function. Heart 2003; 89(4): 449-50.
  • Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG. Left ventricular long-axis diastolic function is augmented in the hearts of endurance-trained compared with strength-trained athletes. Clin Sci (Lond) 2002; 103(3): 249-57.
  • Vinereanu D, Khokhar A, Tweddel AC, Cinteza M, Fraser AG. Estimation of global left ventricular function from the velocity of longitudinal shortening. Echocardiography 2002; 19(3): 177-85.
  • Vinereanu D, Fraser AG, Robinson M, Lee A, Tweddel A. Adenosine provokes diastolic dysfunction in microvascular angina. Postgrad Med J 2002; 78(915): 40-2.
  • Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 2001; 88(1): 53-8.
  • Vinereanu D, Musumeci F, Fraser AG. Diagnosis of Myocardial Abscess After Acute Myocardial Infarction by Transesophageal Echocardiography: Case Report and Short Review of Published Data. Echocardiography 1999; 16(6): 581-584.
  • Vinereanu D, Ionescu AA, Fraser AG. Assessment of left ventricular long axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation. Heart 2001; 85(1): 30-6.
  • Vinereanu D, Khokhar A, Fraser AG. Reproducibility of pulsed wave tissue Doppler echocardiography. J Am Soc Echocardiogr 1999; 12(6): 492-9.
  • Ionescu AA, Vinereanu D, Wood A, Fraser AG. Periaortic fat pad mimicking an intramural hematoma of the thoracic aorta: lessons for transesophageal echocardiography. J Am Soc Echocardiogr 1998; 11(5): 487-90.

 

 

Book chapters (international publishers):

  1. Florescu, R. Darabont, D. Vinereanu. Echocardiographic assessment of the aorta. In: New Approaches to the Aortic Disease: from Valve to Abdominal Bifurcation. Edited by: IC. Tintoiu, A. Ursulescu, J. Elefteriades, MC. Underwood, I. Droc. Elsevier Publishing, 2017 (in press).
  2. Mihaila, D. Vinereanu, R. Lang. The normal mitral valve by 3D echocardiography. 2016 (in press).
  3. Florescu, D. Vinereanu. Echocardiography in coronary artery bypass grafting failure. In: Coronary Graft Failure – State of the Art. Edited by: IC. Tintoiu, MJ. Underwood, SP. Cook, H. Kitabata, A. Abbas. Springer International Publishing, 2016 (in press).
  4. Badano, S. Mihaila, D. Muraru, D. Vinereanu, S. Iliceto. Functional classification of secondary mitral valve regurgitation. In: Secondary mitral regurgitation at a glance. Edited by: P. Lancellotti, K. Fattouch. Springer Science & Business media, New York, 2014: 19-28.
  5. Vinereanu, M. Florescu. Cardiac Adaptation in Athletes – Multimodality Imaging Assessment. In: Adaptation Biology and Medicine – New Chalenges. Edited by: LM. Popescu, AR. Hargens, PK. Singal. Narosa Publishing House, New Delhi, 2014: 317-329.
  6. Vinereanu D, AO. Ciobanu. The role of ACE-inhibitors in the management of arterial hypertension. Recommendations from guidelines and insights from literature. In: Zofenopril, from pharmacology to patient outcomes. Content Ed Net International Medical Publishing Solutions, Rome, 2014: 5-10.
  7. Vinereanu. Risk factors for atherosclerotic disease: present and future. In: Cardiovascular benefits of omega-3 polyunsaturated fatty acids. Edited by: B. Maisch, R. Oelze. IOS Press, Netherlands, 2007: 7-45.
  8. Fraser, D. Vinereanu. Left ventricular hypertrophy, hypertrophic cardiomyopathy, and athelete’s heart. In: Doppler Myocardial Imaging. A textbook. Edited by: GR. Sutherland, L. Hatle, J. D’Hooge, P. Claus, BH. Bijnens. BSWK bvba, Belgium, 2006: 225-251.
  9. Vinereanu. Stress echocardiography in aortic regurgitation: do we have better alternative? In: Clinical Echocardiography – Educational series, Working Group on Echocardiography of the European Society of Cardiology. Edited by: M. Campana, AG. Fraser, A. Distante eds. CD Vol 1, 1998.